{"commentary":{"count":3,"free_build_floor":8,"listing_floor":3,"by_channel":{"youtube":2,"podcast":1},"note":"Indexed podcasts, YouTube videos and X posts that name this trial. A report screens them, searches for more and cites what clinicians said when it is built."},"free_build":{"available":false},"name":"ONTRK","nct_id":"NCT03182257","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=ontrk-nct03182257. The price is fixed at order. We build the report after the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":750,"size":"focused","size_rule":"Focused: 1–12 commentary sources"},"registry":{"acronym":"ONTRK","arms":[{"description":"Single Ascending doses of ONO-7579","label":"ONO-7579 Part A","type":"EXPERIMENTAL"},{"description":"Expansion phase of ONO-7579","label":"ONO-7579 Part B","type":"EXPERIMENTAL"}],"collaborators":[],"completion_date":{"date":"2018-01-30","type":"ACTUAL"},"conditions":["Solid Tumor"],"enrollment":{"count":1,"type":"ACTUAL"},"has_results":false,"interventions":[{"name":"ONO-7579","type":"DRUG"}],"last_update":"2019-09-13","lead_sponsor":"Ono Pharmaceutical Co., Ltd.","official_title":"An Open-label, Multi-center, Dose-escalation and Expansion Study to Evaluate the Safety and Efficacy of ONO-7579 in Patients With Advanced Solid Tumors/ NTRK Gene Fusion Positive Advanced Solid Tumors","overall_status":"TERMINATED","phases":["PHASE1"],"primary_completion_date":{"date":"2018-01-30","type":"ACTUAL"},"primary_outcomes":[{"measure":"Part A: Incidence, nature and severity of Adverse Events","timeFrame":"up to 28 days"},{"measure":"Part A: Clinically significant changes in physical examinations","timeFrame":"up to 28 days"},{"measure":"Part A: Clinically significant changes in neurological examinations","timeFrame":"up to 28 days"},{"measure":"Part A: Clinically significant changes in vital signs and electrocardiogram - including the evaluation of the QT interval","timeFrame":"up to 28 days"},{"measure":"Part B: Overall Response Rate (ORR)","timeFrame":"up to 24 months"}],"references":[],"start_date":{"date":"2017-07-12","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Study of ONO-7579 in Patients With Advanced Solid Tumors/ NTRK Gene Fusion Positive Advanced Solid Tumors","url":"https://clinicaltrials.gov/study/NCT03182257"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"2.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/ontrk-nct03182257"}